Answers are grounded in this paper and cite their sources.
Higher depressive and anxiety symptoms predict disability progression in progressive MS, suggesting their prognostic value for personalized treatment.
Higher HADS scores, particularly depressive symptoms, predicted disability progression. These findings indicate prognostic value of patient-reported outcomes in predicting disease worsening and their potential use in guiding personalised treatment in progressive MS.
No takes yet. Share an insight, caveat, or question.
Kranenbarg et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: